Table 2.

Comparison of serum and tissue oxidant and antioxidant parameters.

Parameters	Group 1	Group 2	Group 3	Group 4
	(n = 7)	(n = 7)	(n = 7)	(n = 7)
Serum
MDA (mmol/mL)	0.73 ± 0.17	1.67 ± 0.32d	1.28 ± 0.21b	0.90 ± 0.26c,e
TOS (μmol/L)	33.59 ± 11.23	80.30 ± 11.26d	52.73 ± 12.48c	39.07 ± 7.07c,e
NO (μM/L)	4.85 ± 0.39	5.80 ± 0.46a	5.41 ± 0.32c	4.90 ± 0.32b,c
TNF-α (pg/mL)	2.72 ± 1.45	18.50 ± 10.01a	9.01 ± 2.06b	5.77 ± 2.34b,c
TAC (mmol/L)	1.32 ± 0.10	0.87 ± 0.30a	1.18 ± 0.10b	1.56 ± 0.11e,f
PON (U/L)	197.03 ± 37.63	124.61 ± 15.81a	145.67 ± 7.75b	157.70 ± 10.25b,c
Peritoneal tissue
MDA (mmol/mL)	0.12 ± 0.25	1.31 ± 0.41d	0.59 ± 0.35b	0.12 ± 0.07c,e
TOS (μmol/L)	7.16 ± 3.53	45.90 ± 26.57a	14.18 ± 4.58b	8.77 ± 4.11b,c
NO (μM/L)	3.95 ± 0.87	6.65 ± 1.36a	6.00 ± 0.52	5.29 ± 0.22b,c
TNF-α (pg/mL)	116.39 ± 42.36	487.21 ± 238.44a	265.22 ± 52.74b	136.83 ± 24.26b,f
TAC (mmol/L)	0.80 ± 0.11	0.34 ± 0.08d	0.47 ± 0.064b	0.66 ± 0.14c,e
PON (U/L)	12.74 ± 3.32	1.83 ± 2.54d	4.82 ± 1.37b	8.34 ± 1.14e,f

MDA: malondialdehyde, NO: nitric oxide, TNF-α: tumor necrosis factor alpha, TAC: total antioxidant capacity, TOS: total oxidant stress, and PON: paraoxonase.

  ^a p < 0.005 as compared to group 1, ^b p < 0.005 as compared to group 2, ^c p < 0.005 as compared to group 3, ^d p < 0.001 as compared to group 1, ^e p < 0.001 as compared to group 2, and ^f p < 0.001 as compared to group 3.